Treatment of patients presenting with in-stent restenosis (ISR) remains a challenge \[[@CR1]\]. Neoatherosclerosis may constitute the underlying substrate of ISR \[[@CR2]\]. We present a patient who developed very late 'edge ISR' caused by neoatherosclerosis.

A 63-year-old man presented with effort angina. Twelve years before, he received a bare-metal stent (BMS) in the left anterior descending coronary artery. Ten years later, repeated angiography showed an excellent stent result. Currently, coronary angiography showed a tight lesion at the distal edge of the stent (Fig. [1a](#Fig1){ref-type="fig"}). Optical coherence tomography (OCT) revealed mild, uniform, neointimal tissue proliferation along the stent. However, its distal segment showed neoatherosclerosis which, near the stent edge, progressed into a ruptured occlusive fibroatheroma with thrombus (Fig. [1b](#Fig1){ref-type="fig"}--[d](#Fig1){ref-type="fig"}). Immediately distal to the stent edge, a large lipid plaque was also recognized (Fig. [1e](#Fig1){ref-type="fig"}). A drug-eluting stent (DES) was successfully implanted. Repeated OCT confirmed excellent stent expansion and apposition, but unravelled multiple areas with plaque prolapse and residual thrombus (Fig. [2](#Fig2){ref-type="fig"}).Fig. 1**a** Coronary angiography revealing a severe in-stent restenosis at the distal edge of the stent (*arrow*). **b--e** OCT before intervention. **b** Distal segment of the stent showing a glistening neointima covering dark tissue (+) overlying the stent struts. **c--d** Ruptured fibroatheroma (*yellow arrow*) with some protruding thrombus nearly completely obscuring the stent struts (only visualized in **d** from 4 to 7 o'clock), (*b* residual blood). **e** Occlusive lipid plaque (+) immediately distal to the stent edge. (+)= Lipid pools. (\*)= indicates wire artifactFig. 2OCT findings after DES implantation. A nicely expanded stent with multiple areas of tissue prolapse (*white arrows*) is depicted (**a--c**). A double stent layer can be visualized with residual lipid tissue (+). **d** New stent, extending beyond the previous stent, disclosing the underlying lipid plaque (+) and prolapsing tissue (*white arrow*). (\*) = indicates wire artifact

Neoatherosclerosis occurs less frequently and later in patients receiving BMS as compared with those treated with DES \[[@CR1], [@CR2]\]. Complicated neoatherosclerosis (rupture of a thin-cap fibroatheroma) may explain unstable clinical presentations in patients with ISR and in those with very-late stent thrombosis \[[@CR2]\]. Due to its spatial resolution (15 μm), OCT represents the technique of choice for the diagnosis of neoatherosclerosis \[[@CR3]\]. Edge-ISR occurs more frequently in patients with DES-ISR than in those with BMS-ISR \[[@CR4]\] and repeat stenting has been advocated in this setting \[[@CR5]\]. However, to the best of our knowledge, complicated neoatherosclerosis causing edge-ISR has not been previously reported.
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